Dear Sir or Madam, I am reaching out to express my interest in contributing the data from a scRNA-seq study focused on convalescent COVID-19 patients to the COVID-19 Cell Atlas. Our paper is currently in review, and we would like the dataset to be made publicly available upon publication. I have reviewed the data format requirements for submission. Before proceeding, I would like to inquire if there are any additional considerations or specific guidelines that I should be aware of to ensure a smooth submission process, or if it really is just the submission of the data itself? Thank you for your time and assistance! Kind regards, Lilly May --------------------------- Lilly May Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute – Beutenbergstrasse 11a 07745 Jena Germany https://urldefense.proofpoint.com/v2/url?u=http-3A__www.zielinskilab.com&d=DwIF-g&c=D7ByGjS34AllFgecYw0iC6Zq7qlm8uclZFI0SqQnqBo&r=YCVDjNHxAgv8-gpjr0Xb48Y9Vk9U8oXzH6wskU6pf14&m=LAxIhPbJSrI289Y7UTZLBVbDUa8Waxp4VlwSszjKqRxidNA5lji-Wq5N3qFQN4y-&s=M75AEFDC0a2lLzmLfs8AnH3XEPm7-65I4Ux23KcMWi0&e= <https://urldefense.proofpoint.com/v2/url?u=http-3A__www.zielinskilab.com&d=DwIF-g&c=D7ByGjS34AllFgecYw0iC6Zq7qlm8uclZFI0SqQnqBo&r=YCVDjNHxAgv8-gpjr0Xb48Y9Vk9U8oXzH6wskU6pf14&m=LAxIhPbJSrI289Y7UTZLBVbDUa8Waxp4VlwSszjKqRxidNA5lji-Wq5N3qFQN4y-&s=M75AEFDC0a2lLzmLfs8AnH3XEPm7-65I4Ux23KcMWi0&e= >